Insulin Glargine/Breast Cancer Link Seen Again in Type 2 Diabetes

A study in more than 22,000 women reports a weak signal of breast-cancer risk with insulin glargine vs NPH insulin, but the researchers caution that this should not change clinical practice.

Source: Insulin Glargine/Breast Cancer Link Seen Again in Type 2 Diabetes

About the Author

NutriScape Staff Writer